NO20021860D0 - Formulering av substituerte benzimidazoler - Google Patents

Formulering av substituerte benzimidazoler

Info

Publication number
NO20021860D0
NO20021860D0 NO20021860A NO20021860A NO20021860D0 NO 20021860 D0 NO20021860 D0 NO 20021860D0 NO 20021860 A NO20021860 A NO 20021860A NO 20021860 A NO20021860 A NO 20021860A NO 20021860 D0 NO20021860 D0 NO 20021860D0
Authority
NO
Norway
Prior art keywords
formulation
substituted benzimidazoles
benzimidazoles
substituted
Prior art date
Application number
NO20021860A
Other languages
English (en)
Other versions
NO20021860L (no
NO329545B1 (no
Inventor
Mikael Bruells
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Publication of NO20021860D0 publication Critical patent/NO20021860D0/no
Publication of NO20021860L publication Critical patent/NO20021860L/no
Publication of NO329545B1 publication Critical patent/NO329545B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Inorganic Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Plural Heterocyclic Compounds (AREA)
NO20021860A 1999-10-22 2002-04-19 Stabil flytende formulering, fremgangsmate for fremstilling derav, samt anvendelse derav i medisin NO329545B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9903831A SE9903831D0 (sv) 1999-10-22 1999-10-22 Formulation of substituted benzimidazoles
PCT/SE2000/001992 WO2001028558A1 (en) 1999-10-22 2000-10-13 Formulation of substituted benzimidazoles

Publications (3)

Publication Number Publication Date
NO20021860D0 true NO20021860D0 (no) 2002-04-19
NO20021860L NO20021860L (no) 2002-05-21
NO329545B1 NO329545B1 (no) 2010-11-08

Family

ID=20417464

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20021860A NO329545B1 (no) 1999-10-22 2002-04-19 Stabil flytende formulering, fremgangsmate for fremstilling derav, samt anvendelse derav i medisin

Country Status (36)

Country Link
US (1) US6730685B1 (no)
EP (1) EP1274427B1 (no)
JP (1) JP2003512327A (no)
KR (1) KR100785603B1 (no)
CN (1) CN1213751C (no)
AR (1) AR029005A1 (no)
AT (1) ATE304851T1 (no)
AU (1) AU782866B2 (no)
BG (1) BG65580B1 (no)
BR (1) BR0014895A (no)
CA (1) CA2425199C (no)
CO (1) CO5261533A1 (no)
CY (1) CY1106055T1 (no)
CZ (1) CZ20021375A3 (no)
DE (1) DE60022789T2 (no)
DK (1) DK1274427T3 (no)
EE (1) EE05175B1 (no)
ES (1) ES2246903T3 (no)
HK (1) HK1051142A1 (no)
HU (1) HUP0203121A3 (no)
IL (2) IL149107A0 (no)
IS (1) IS2196B (no)
MX (1) MXPA02003900A (no)
MY (1) MY131971A (no)
NO (1) NO329545B1 (no)
NZ (1) NZ518155A (no)
PL (1) PL199868B1 (no)
RU (1) RU2286782C2 (no)
SE (1) SE9903831D0 (no)
SI (1) SI1274427T1 (no)
SK (1) SK286266B6 (no)
TR (1) TR200201103T2 (no)
TW (1) TWI236372B (no)
UA (1) UA74347C2 (no)
WO (1) WO2001028558A1 (no)
ZA (1) ZA200202905B (no)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002012225A1 (fr) * 2000-08-04 2002-02-14 Takeda Chemical Industries, Ltd. Sels de composé à base de benzimidazole et leurs applications
US7396841B2 (en) * 2000-08-18 2008-07-08 Takeda Pharmaceutical Company Limited Injections
MY137726A (en) * 2000-11-22 2009-03-31 Nycomed Gmbh Freeze-dried pantoprazole preparation and pantoprazole injection
GB2376231A (en) * 2001-06-06 2002-12-11 Cipla Ltd Benzimidazole-cyclodextrin inclusion complex
FR2845916B1 (fr) * 2002-10-21 2006-07-07 Negma Gild Composition pharmaceutique associant le tenatoprazole et un antagoniste des recepteurs h2 a l'histamine
FR2845917B1 (fr) * 2002-10-21 2006-07-07 Negma Gild Composition pharmaceutique associant le tenatoprazole et un anti-inflammatoire
FR2845915B1 (fr) * 2002-10-21 2006-06-23 Negma Gild Utilisation du tenatoprazole pour le traitement du reflux gastro-oesophagien
FR2848555B1 (fr) 2002-12-16 2006-07-28 Negma Gild Enantiomere(-)du tenatoprazole et son application en therapeutique
CN100558726C (zh) * 2003-02-24 2009-11-11 田边三菱制药株式会社 泰妥拉唑的对映体及其在治疗中的应用
TWI372066B (en) * 2003-10-01 2012-09-11 Wyeth Corp Pantoprazole multiparticulate formulations
US20060089376A1 (en) * 2004-10-27 2006-04-27 Joshi Ramesh A Tenatoprazole salts and process of preparation thereof
US20090111856A1 (en) * 2006-05-09 2009-04-30 Mikael Brulls Parenteral Formulation Comprising Proton Pump Inhibitor Sterilized in its Final Container by Ionizing Radiation
CN100411613C (zh) * 2006-12-08 2008-08-20 中国药科大学 一种奥美拉唑速释固体制剂及其制备方法
EP3218510B1 (en) 2014-11-13 2019-01-02 3M Innovative Properties Company Kit comprising atp-diphosphohydrolase for detecting bacterial atp in a sample
EP3288556A4 (en) 2015-04-29 2018-09-19 Dexcel Pharma Technologies Ltd. Orally disintegrating compositions
US10076494B2 (en) 2016-06-16 2018-09-18 Dexcel Pharma Technologies Ltd. Stable orally disintegrating pharmaceutical compositions

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE7804231L (sv) 1978-04-14 1979-10-15 Haessle Ab Magsyrasekretionsmedel
SE8301182D0 (sv) 1983-03-04 1983-03-04 Haessle Ab Novel compounds
IL75400A (en) 1984-06-16 1988-10-31 Byk Gulden Lomberg Chem Fab Dialkoxypyridine methyl(sulfinyl or sulfonyl)benzimidazoles,processes for the preparation thereof and pharmaceutical compositions containing the same
JPS6150978A (ja) 1984-08-16 1986-03-13 Takeda Chem Ind Ltd ピリジン誘導体およびその製造法
AU4640985A (en) 1984-08-31 1986-03-06 Nippon Chemiphar Co. Ltd. Benzimidazole derivatives
DK399389A (da) * 1988-08-18 1990-02-19 Takeda Chemical Industries Ltd Injicerbare oploesninger
JP2536173B2 (ja) * 1988-08-18 1996-09-18 武田薬品工業株式会社 注射剤
KR930000861B1 (ko) 1990-02-27 1993-02-08 한미약품공업 주식회사 오메프라졸 직장투여 조성물
SK279554B6 (sk) 1992-07-28 1998-12-02 Astra Aktiebolag Jeho analógy
SE9301830D0 (sv) 1993-05-28 1993-05-28 Ab Astra New compounds
TW359614B (en) 1993-08-31 1999-06-01 Takeda Chemical Industries Ltd Composition containing benzimidazole compounds for rectal administration
US5726181A (en) 1995-06-05 1998-03-10 Bionumerik Pharmaceuticals, Inc. Formulations and compositions of poorly water soluble camptothecin derivatives
US5840737A (en) 1996-01-04 1998-11-24 The Curators Of The University Of Missouri Omeprazole solution and method for using same
US5877205A (en) 1996-06-28 1999-03-02 Board Of Regents, The University Of Texas System Parenteral paclitaxel in a stable non-toxic formulation
SE510643C2 (sv) 1997-06-27 1999-06-14 Astra Ab Termodynamiskt stabil omeprazol natrium form B
ATE429210T1 (de) * 1998-01-20 2009-05-15 Applied Analytical Ind Inc Orale flüssige zusammensetzungen

Also Published As

Publication number Publication date
CY1106055T1 (el) 2011-04-06
CA2425199A1 (en) 2001-04-26
DE60022789D1 (de) 2006-02-02
DE60022789T2 (de) 2006-06-22
BG106602A (en) 2002-12-29
KR100785603B1 (ko) 2007-12-14
AU782866B2 (en) 2005-09-01
ZA200202905B (en) 2003-07-14
JP2003512327A (ja) 2003-04-02
WO2001028558A1 (en) 2001-04-26
MXPA02003900A (es) 2002-09-30
MY131971A (en) 2007-09-28
IS6347A (is) 2002-04-17
IL149107A (en) 2008-04-13
SI1274427T1 (sl) 2006-02-28
EE05175B1 (et) 2009-06-15
CN1213751C (zh) 2005-08-10
HUP0203121A2 (hu) 2003-01-28
KR20020059637A (ko) 2002-07-13
CN1382048A (zh) 2002-11-27
SK5392002A3 (en) 2002-10-08
HUP0203121A3 (en) 2004-01-28
TR200201103T2 (tr) 2002-08-21
NO20021860L (no) 2002-05-21
PL199868B1 (pl) 2008-11-28
DK1274427T3 (da) 2005-12-27
NO329545B1 (no) 2010-11-08
CZ20021375A3 (cs) 2002-09-11
AU1182301A (en) 2001-04-30
HK1051142A1 (en) 2003-07-25
TWI236372B (en) 2005-07-21
EP1274427A1 (en) 2003-01-15
CA2425199C (en) 2010-12-07
UA74347C2 (uk) 2005-12-15
EE200200204A (et) 2003-04-15
BG65580B1 (bg) 2009-01-30
ES2246903T3 (es) 2006-03-01
IS2196B (is) 2007-01-15
ATE304851T1 (de) 2005-10-15
SK286266B6 (sk) 2008-06-06
SE9903831D0 (sv) 1999-10-22
NZ518155A (en) 2004-07-30
US6730685B1 (en) 2004-05-04
AR029005A1 (es) 2003-06-04
EP1274427B1 (en) 2005-09-21
PL354926A1 (en) 2004-03-22
CO5261533A1 (es) 2003-03-31
BR0014895A (pt) 2002-06-18
RU2286782C2 (ru) 2006-11-10
IL149107A0 (en) 2002-11-10

Similar Documents

Publication Publication Date Title
NO20022979L (no) Anvendelse av organiske forbindelser
NO20013369D0 (no) Arylpiperazinyl-cykloheksyl-indol-derivater for behandling av depresjon
AR026045A1 (es) Formulaciones de liberacion prolongada de derivados de eritromocina
DK1189853T3 (da) Betonformulering
ID30233A (id) Antibiotika ketolida
NO20020185L (no) Formuleringer av IL-11
NO20021860L (no) Formulering av substituerte benzimidazoler
NO20021834L (no) Orale formuleringer av anti-tumorforbindelser
NO20016151D0 (no) Fremstilling av substituerte piperidin-4-oner
NO20021730D0 (no) Ny formulering av mirtazapin
LU90483B1 (fr) Compositions nouvelles de m-thanesulfonate de parox-tine
NO20023785L (no) Vanndispergerbar formulering av paroxetin
EE200200389A (et) Imidasooli uued derivaadid
PT1178984E (pt) Derivados de 1-trifluorometil-4-hidroxi-7-piperidinilamimometilcromano
NO20014845D0 (no) Anvendelse av arylalkanoylpyridaziner
DE60012953D1 (de) 3-amino-2-phenylpiperidinderivate als substanz p antagonisten
PT1175417E (pt) Compostos substituidos de benzolactamas
NO20016030L (no) Derivater av 4'-demykarosyl-8a-aza-8a-homotylosin
NO20022446L (no) Etere av O-desmetyl-venlafaxine
NO20005856L (no) Anvendelse av 1,1-diokso-perhydro-1,2,4-tiadiaziner
NO993313L (no) Derivater av 5-nitrofurfural
SE9902239D0 (sv) Kornisch bestående av flera delar
SE9902902D0 (sv) New formulation
SE9903391D0 (sv) Novel formulation
NO993425D0 (no) Beskyttelse av kabler

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees